PFO
GRCL

Pathstone Family Office’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Pathstone Family Office’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		$142K Buy
49,158
+23,245
+90% +$66.9K ﹤0.01% 1555
2023
Q2 		$98.7K Buy
+25,913
New +$98.7K ﹤0.01% 1187